BOSTON, Nov. 21, 2008 – Palomar Medical Technologies, Inc. (Nasdaq: PMTI), a researcher and developer of light-based systems for cosmetic treatments, announced the formation of a Fractional Technology Open Patent Program with Reliant Technologies, Inc. to offer licenses in the professional field to key intellectual property in the fractional space. The FTOPP contains six fundamental fractional patent families, including issued patents and pending patent applications owned or controlled by Palomar, Reliant and Massachusetts General Hospital. In addition to the FTOPP, Reliant and Palomar have entered into certain cross-licenses between the two companies.
Goodwin Procter attorneys Kingsley L. Taft, Kevin V. Lam, Gessingga N. Storer and Maggie L. Wong provided legal counsel to Palomar Medical Technologies for this set of transactions.
About Goodwin Procter
Goodwin Procter LLP is one of the nation’s leading law firms with 900 attorneys in offices in Boston, London, Los Angeles, New York, San Diego, San Francisco, Silicon Valley, and Washington, D.C. The firm’s core areas of practice are corporate, litigation and real estate, with specialized areas of focus that include financial services, private equity, technology, REITs and real estate capital markets, intellectual property, tax and products liability. Information may be found at www.goodwinprocter.com.